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ABSTRACT
High frequencies of gene targeting can be achieved
by infection of mammalian cells with recombinant
adeno-associated virus (rAAV) vectors [D. W.
Russell and R. K. Hirata (1998) Nature Genet., 18,
325–330; D. W. Russell and R. K. Hirata (2000)
J. Virol., 74, 4612–4620; R. Hirata et al. (2002)
Nat. Biotechnol., 20, 735–738], but the mechanism
of targeting is unclear and random integration
often occurs in parallel. We assessed the role of
specific DNA repair and recombination pathways in
rAAV gene targeting by measuring correction of a
mutated enhanced green fluorescent protein (EGFP)
gene in cells where homologous recombination (HR)
or non-homologous end-joining (NHEJ) had been
suppressed by RNAi. EGFP-negative cells were
transduced with rAAV vectors carrying a different
inactivating deletion in the EGFP, and in parallel
with rAAV vectors carrying red fluorescent protein
(RFP). Expression of RFP accounted for viral
transduction efficiency and long-term random
integration. Approximately 0.02% of the infected
GFP-negative cells were stably converted to GFP
positive cells. Silencing of the essential NHEJ
component DNA-PK had no significant effect on
the frequency of targeting at any time point
examined. Silencing of the SNF2/SWI2 family mem-
bers RAD54L or RAD54B, which are important for
HR, reduced the rate of stable rAAV gene targeting
 5-fold. Further, partial silencing of the Rad51
paralogue XRCC3 completely abolished stable
long-term EGFP expression. These results show
that rAAV gene targeting requires the Rad51/Rad54
pathway of HR.
INTRODUCTION
The correction of mutations in genomic DNA in situ is one of
the most attractive approaches for gene therapy of inherited
single gene disorders. This process is inherently non-
mutagenic and very likely to conserve appropriately regulated
expression of the repaired gene product. Gene targeting
through homologous recombination (HR) is the most accurate
and versatile mechanism for such correction. However, HR
occurs in human somatic cells with very low frequencies of
about 10
 7 (1). Efforts directed towards improving the fre-
quency of gene repair have lead to the development of
numerous oligonucleotide-based strategies, involving deliv-
ery of plain DNA by transfection or injection. Triplex-
forming oligonucleotides (TFOs) can induce recombination
between a polypurine/polypyrimidine rich DNA duplex and
unlinked donor molecule by introducing damage to such
duplex. The maximum frequency of targeted modiﬁcation
achieved with TFOs in vivo was 10
 4 (2). Alternatively, the
best frequency for gene editing with chimeric RNA-DNA
oligonucleotides (RDOs) or chimeraplasts was 1% of all
muscle ﬁbers positive for the chimeraplast DNA mostly
close to the injection site (3). Chimeraplast and single-
stranded oligodeoxynucleotide-mediated gene repair (4)
most likely involves a mismatch repair mechanism and is
restricted to repair of point mutations. A major limitation of
the ability of injected chimeraplast to promote gene conver-
sion in muscle appears to be the restricted uptake of chimer-
aplasts into ﬁbers due to inefﬁcient delivery of the repair
substrate in vivo. A short-fragment homologous replacement
(SFHR) strategy allows alteration of as many as 4 bp, with a
maximum reported frequency of about 0.4% (5).
Viral delivery systems based on retrovirus, adenovirus and
adeno-associated virus (AAV) overcome some of these lim-
itations by offering more efﬁcient DNA delivery and by
accommodating longer stretches of homology with the
genomic locus to allow a broad spectrum of targeted
modiﬁcations. The best targeting frequencies achieved by
retrovirus and adenovirus vectors, however, were only
comparable to those shown by DNA transfection (6,7). In
contrast, recombinant adeno-associated virus (rAAV) vectors
comprised of single-stranded DNA with unique inverted ter-
minal repeats (ITRs), reach the nucleus in multiple copies and
have been shown to target homologous sequences in cultured
human cells with an efﬁciency of up to 1% [reviewed in
(8,9)]. This property of rAAV combined with its broad host
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advancements in viral re-targeting through capsid manipula-
tion (10) make rAAV an attractive system for gene correction
and, alternatively, for gene disruption aimed at generating
knock-outs in cultured human primary cells or cell lines
(11,12). Still, the rate of AAV-mediated gene targeting
alone is not sufﬁciently high for gene therapy through gene
correction in vivo, where the accompanying potentially muta-
genic random integration events cannot be selected against.
In cell culture, the rate of random integration was at 10%,
and integration in vivo is known to occur predominantly in
transcriptionally active genes (13,14).
Similar to conventional gene targeting the frequency of
rAAV-mediated targeting was elevated signiﬁcantly by the
introduction of DNA double-strand breaks (DSBs) at the tar-
geted site (15,16). This supports the hypothesis that compo-
nents of DSB repair pathways, such as non-homologous
end-joining (NHEJ) or HR are involved in rAAV-mediated
gene targeting. Studies in SCID mice suggest that DNA-PK
promotes circularization of linear double-stranded rAAV gen-
omes (17). It has also been shown that proteins involved in
both NHEJ and HR, such as KU86 and RAD52 bind to the
AAV genome and affect the transduction efﬁciency, possibly
via a modiﬁcation of AAV DNA processing (18). However, it
remains unclear which pathway and proteins mediate gene
targeting by rAAV.
The unique structure of the rAAV vector DNA with an
unusually short stretch of double-stranded (ds) DNA transi-
tioning into the extended single-strand region between the
ITRs, was found to be important for targeting. Addition of
self-complementary double-stranded genomes to the native
single-stranded rAAV DNA did not improve the targeting
reaction, and dimeric vector molecules, which do not contain
the characteristic ITRs and ss–dsDNA transition regions,
failed to target efﬁciently (19). The largely single-stranded
genomes represent the majority of vector forms in the
infected cell for several days (20), a period of time that
should be sufﬁcient for targeting reactions to occur. There-
fore, DNA repair factors or protein complexes involved in
the cellular pathways of processing of ssDNA of speciﬁc
DNA structures, such as ITRs, or of ss–ds transitional regions
might be key to gene targeting by rAAV. Deciphering the
mechanism of rAAV gene targeting may in the future allow
manipulation of potentially competing pathways in order to
both enhance targeting rates and lower random integration
events. In this study we identiﬁed components of the cellular
DNA repair/recombination machinery, which are essential for
efﬁcient rAAV-mediated gene targeting.
MATERIALS AND METHODS
Cloning of mutant enhanced green fluorescent protein
(EGFP) target and substrate vectors
Standard molecular biology techniques were used to modify
all plasmids (21). The pEGFP C1 expression plasmid
(BD Biosciences Clontech, Palo Alto, CA) was used as a
source of the EGFP gene and also as a plasmid backbone
for the genomic target. Selection of the cells containing the
target on hygromycin was made possible by replacing the
neomycin phosphotransferase gene (neo) of pEGFP C1 with
a hygromycin phosphotransferase gene (hyg) from pSecTag-
Hygro (InVitrogen, Carlsbad, CA). A PCR fragment spanning
bases 1–198 of the EGFP gene was generated using the fol-
lowing oligonucleotides A-NheI-forward: 50-TGAACCGTC-
AGATCCGCTAG-30 and A-SpeI-reverse 50-GTACTAGTG-
GGTGGTCACGAGG-30. Another PCR fragment spanning
bases 230–740 was ampliﬁed using oligonucleotides C-
SpeI-forward: 50-GACTAGTTGAAGCAGCACGAC-30 and
B&C-XhoI-reverse: 50-TGAGCTCGAGATCTGAGTCCG-30.
The EGFP gene resulting from joining these two PCR frag-
ments via a SpeI endonuclease site contained a deletion of
32 bases and served as a mutant target. This EGFPD32 gene
w a su s e dt or e p l a c et h ei n t a c tEGFP gene in pEGFP C1-Hyg
linearized with NheI/XhoI to yield p EGFPD32 (Figure 1A).
Another mutant gene lacking the ﬁrst 14 bases—D14EGFP
(including the start codon) of the wild-type EGFP gene was
generated by ampliﬁcation from the pEGFP C1 template
with oligonucleotides B-NotI-forward: 50-CAAGCGGCCG-
CAGCTGTTCAC-30 and B&C-XhoI-reverse shown above.
This mutant was used to replace the GFP gene in NotI–
XhoI digested proviral rAAV2 plasmid pTRUF11 (22).
Both truncated EGFP mutants were conﬁrmed by sequencing.
The cytomegalovirus (CMV) enhancer and the CAAT and
TATA signals of the chicken b-actin (CBA) promoter in
pTRUF11 was replaced by a portion of the yeast Pichia
pastoris AOX1 transcription termination sequence thus
restricting additional homology between the viral template
and the pEGFPD32 genomic target to 100 bp upstream of
the EGFP start. The resulting plasmid pTR-Neo was used
for the production of rAAV-Neo. Plasmid pTR-RFP was con-
structed by replacing the PSV40-neo expression cassette on
pTR-Neo with a red ﬂuorescent protein (RFP) expressed
under the mouse cytomegalovirus promoter (mCMV). This
plasmid was used for preparation of rAAV-RFP. The RFP
gene was ampliﬁed from pDsRed2.1 (BD Biosciences
Clontech, Palo Alto, CA) and mCMV was derived from
pSEAP-Hyg (gift from Dr Karen Anthony). Viruses contain-
ing substrate with extended homology to the target sequence
were created by adding 1.009 kb fragment from the backbone
of pEGFP C1 to the 30 end of the GFP mutant gene on
pTR-Neo or pTR-RFP. The resulting vectors pTR-NeoX and
pTR-RFPX were used for production of rAAV-NeoX and
rAAV-RFPX, respectively (Figure 1B and C). All pTRUF11-
based plasmids were cloned and propagated in SURE2 cells
(BD Biosciences Clontech, Palo Alto, CA). Plasmid DNA
was puriﬁed using a kit (Qiagen Inc., Valencia, CA).
Production, purification and titration of
rAAV vector stocks
Recombinant AAV2 was produced in 293T cells using a
dual-vector, calcium phosphate-mediated transfection
approach and viral stocks were puriﬁed as described previ-
ously (22). Plasmid pDG carries the Rep and Cap genes
necessary for rAAV2 packaging as well as the adenovirus
helper functions (E2A, E4, VA). Iodixanol fractions contain-
ing the virus particles were placed directly in a 10 kDa cut-off
Slide-A-Lyser cassette (Pierce, Rockford, IL) and dialyzed
against DMEM at 4 C. The dialysis was complete when the
refraction coefﬁcient of the virus stock was equivalent to
that of a pure DMEM medium. Virus stock aliquotes were
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titers of rAAV were determined by slot-blot hybridization
and/or real-time PCR with GFP-speciﬁc primers (speciﬁed
above) using the SYBR Green I QPCR kit (Qiagen Inc.).
Samples were prepared as described previously (23).
Throughout this study, MOIs were deﬁned as the number of
DNase-resistant rAAV genome particles per cell (gcp/cell).
Cell culture and cell lines
Human glioma cells MO59K and MO59J (24), Phoenix-GP
cells, 293 and 293T cells have been described previously.
All cells were grown in a humidiﬁed chamber at 37 C and
5% CO2. Cells were split and passaged by following standard
procedures. 293, 293T and Phoenix-GP cells were grown in
DMEM containing 4 g of glucose per liter (except for
rAAV production where glucose was 1.5 g/l), 10%
heat-inactivated calf serum (HyClone, Logan, UT), 2 mM
L-glutamine-100 U of penicllin/ml and 100 mgo f
streptomycin/ml. MO59K cells were grown with the same
supplements, except that the base medium was DMEM:F12
(Invitrogen). Cell line MO59KD32 was created by electro-
poration of 10
7 cells with 20 mg of AlwNI linearized plasmid
pEGFPD32. Drug-resistant cells were selected by culturing
in 150 mg of hygromycin (Invitrogen)/ml from day 2 after
electroporation until distinct colonies formed  14 days
after electroporation. Minimum of 24 individual colonies
were picked from each cell line, trypsinized and serially
diluted for further puriﬁcation to single cells in 48-well
plates. Wells containing single colonies were transferred in
duplicate to 24-well plates. After the expansion of these indi-
vidual colonies replica plates were frozen for storage and the
original plates used for DNA isolation for Southern analysis.
In addition, early passage of the polyclonal MO59KD32
population was frozen in aliquots for subsequent rAAV infec-
tion and silencing experiments.
To enable infection with mouse retrovirus for RAD54L
silencing clone MO59KD32 B was used to create a cell line
expressing mouse retroviral ecotropic receptor. This cell line
was generated by transduction with pEco (gift from Dr Saghi
Gaffari) followed by G418 selection (0.3 mg of active com-
pound per ml).
DNA and RNA analysis
Genomic DNA and total RNA from hygromycin resistant
clones were isolated using a DNA tissue kit or RNAeasy
kit, respectively (Qiagen Inc.). Probes for Southern, northern
Figure 1. Schematic representation of the vectors used for gene targeting. (A) Plasmid pEGFPD32 containing the mutant target (thick white arrow) expressed
under human CMV promoter was integrated in the genome of MO59K cells. Thirty-two base pair deletion at position 198 (50-ctgacctacggcgtg-
cagtgcttcagccgctaccccgaccacatgaa-30) was replaced by an in-frame stop-codon supplied within a unique SpeI restriction site (50-CACTAGTTGAAGCa-30).
Resistance to hygromycin was provided by a hygromycin phosphotransferase (Hygro) expressed from an SV40 promoter. (B) Schematic of rAAV used as repair
substrates in gene targeting experiments. All viral vectors consisted of single-stranded DNA enclosed by native AAV subtype 2 inverted repeats. Both substrates
(white arrows) lacked 14 bp from the 50 end of the EGFP gene including the ATG codon (D14EGFP). A short and a long fragment from the P.pastoris
alcohol oxidase termination sequence (Pp AOX TT and TT) replaced the CMV and the CAAT+TATA signals of the CBA/rabbit b-globin promoter (CBA/b-
globin). The rAAV-NeoX contained additional homology to the genomic target (thick black line). The recombinant viruses also contained a neomycin
phosphotransferase gene (Neo) expressed under a HSV-TK promoter. (C) Diagram of the vectors used to test cell infectivity. rAAV-RFPX and rAAV-RFP were
identical to rAAV-NeoX and rAAV-Neo, respectively, except for the replacement of the neomycin phosphotransferase expression cassete with a RFP expression.
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liﬁed from pEGFP C1, pTR-B and pTR-RFP, respectively.
The probe hybridizing to XRCC3 was isolated as 1 kb
EcoRI fragment from pGAGGS-XRCC3 (gift from Dr
Maria Jasin). Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) probe was ampliﬁed by RT–PCR from human
total RNA. Northern and slot-blot hybridization signals
were quantiﬁed by PhosphorImager analysis (Molecular
Dynamics, Sunnyvale, CA).
rAAV gene correction assays
EGFP targeted correction assays were performed in 100 mm
culture dishes seeded with 5 · 10
5 live cells (determined by
trypan-blue exclusion) per dish (70% conﬂuence) at the time
of viral infection. Unless speciﬁed otherwise, MO59KD32
cells were trypsinized, counted, seeded in triplicate and left
to rest for an hour. The cells were transduced with rAAV car-
rying either minimal or extended homology to the target. The
multiplicity of infection (MOI) was 1000, 10 000 or 50 000
genome containing gcp/cell. Twenty-four hours later the
medium containing the virus was replaced. At 48 or 72 h
after infection each plate was passaged and an aliquot
(usually half of the cells by volume) analyzed by a
ﬂuorescence-activated cell scan (FACS, Becton Dickinson)
with settings, FSC E-1, SSC 150, FL1 452 nm, FL2 410 nm
and FL3 500 nm with AmpGain 6.23, 1.22, 1.15, 2.91 and
1, respectively; compensation FL1-1.8% FL2, FL2-41.7%
FL1 and FL3-72.6%-FL2. Each EGFP positive cell was
considered as a single gene correction event. Average gene
correction efﬁciency was calculated from samples collected
from triplicate transduction. Infected cells were then serially
passaged on alternate days and analyzed by ﬂow cytometry
until the percentage of GFP positive cells stabilized. Gene
repair assays comparing MO59KD32 silenced and untreated
cells were similarly performed in triplicate in 60 mm plates
seeded with 3 · 10
5 cells at the time of infection. In addition
to the transduction with rAAV-Neo vectors, cells were
transduced with rAAV-RFP or rAAV-RFPX that served as
a control for the efﬁciency of infection. Cells transduced
with rAAV-SEAP that expresses secreted alkaline phospha-
tase (AP) (gift from Dr Thomas Weber) were used instead
of a non-transduced control.
Discrete analysis of gene correction events
Cells from the MO59KD32 B clone (3 · 10
5) were infected
with rAAV-NeoX vector (MOI ¼ 20 000 particles/cell) in a
60 mm plate. The virus was removed 24 h later. The number
of EGFP positive cells was determined by FACS on day 3
when cells were expanded to 2 · 100 mm plates. EGFP pos-
itive cells were separated from the total infected population
by ﬂuorescence-activated cell sorting on a FACS Vantage
SE with FACS Diva software (BD) on day 5. Single cells
seeded onto 96-well plates were then expanded for cryopre-
servation and isolation of genomic DNA. The presence of
full-length corrected EGFP was conﬁrmed by PCR using
primers spanning a sequence from the 30 end of the CMV pro-
moter (50-TCAGATCCGCTAGCGCTACCGGTC-30) and the
EGFP gene (50-GGTGCGCTCCTGGACGTAGCCTT-30).
The ﬁdelity of repair was conﬁrmed by sequencing of
the PCR product. In addition, genomic DNA from eight
independent GFP positive corrected clones was analyzed by
Southern blot with EGFP-speciﬁc probe.
Design of short-hairpin oligonucleotides and plasmids
for RNA interference
A pool of oligonucleotides for transcriptional silencing was
generated using the Whitehead Institute siRNA prediction
software (http://jura.wi.mit.edu/siRNAext/). Analysis invol-
ving additional position and thermodynamic criteria nar-
rowed the selection to 2–4 sequences for each target
transcript. Unless stated otherwise, DNA oligonucleotides
used to generate short-hairpin RNA (shRNA) were 64 bases
long and shared common structure that differed only in the
mRNA coding sequence: 50-GATCccc(19N)ttcaagaga(19N)-
tttttGGAAA-30. To provide better export of the shRNA to
the cytoplasm the loop of oligonucleotides for downregula-
tion of Rad54L expression contained a native human
sequence derived from miRNA-23 (50-cttcctgtca-30). The oli-
gonucleotide targeting the DNA-PK mRNA starting from
position 6684 had 20 nt of sense and 19 nt of antisense
sequence. The siRNA starting at position 11 838 (or 11 740
on alternatively spliced) on the DNA-PKcs mRNA was
described previously (25). XRCC3 mRNA was targeted for
degradation with oligonucleotide sequences starting at posi-
tions 362, 367, 914 and 2059; Rad54B oligonucleotides
started at positions 475, 1409, 1511 and 1512 of the mRNA
and Rad54L oligonucleotides started at positions 1472 and
2281 of the mRNA.
A mouse stem-cell retrovirus (MSCV) vector system was
used to downregulate the expression of target genes. Prior
to cloning of the DNA oligonucleotides downstream of the
human RNA pol III promoter H1, plasmid pSUPER (Oli-
goEngine Inc., Seattle, WA) was modiﬁed by insertion of a
1 kb ‘stuffer’ sequence between the BamHI and HindIII
restriction sites. The above oligonucleotides were cloned
into pSuper-stuffer by replacing the 1 kb sequence with the
64 bp shRNA. shRNA expression cassette was then sub-
cloned into a pMSCV-PAC vector (BD Biosciences) in the
EcoRI/XbaI sites of the MCS. This enabled production of ret-
roviruses carrying silencing shRNA and subsequent selection
for silenced populations on puromycin (2 mg/ml). To prevent
cleavage of hairpin structures Escherichia coli strain GT116
that lacks the sbcC and sbcD genes was used for plasmid pro-
pagation and maintenance. Prior to nucleofection (Amaxa )
into cells containing targeted substrate the silencing potential
of individual shRNA sequences was evaluated in 293 cells.
Linearized pMSCV vectors were introduced by CaHPO4
transfection, positive cells selected on puromycin and nuclear
extracts analysed by immunoblotting as described below.
Retrovirus vector preparations
MSCViruses expressing shRNA hairpins targeting for
degradation Rad54L RNA were made by transient transfec-
tion of Phoenix-GP cells with pMSCV-sh1472Rad54L and
pMSCV-sh2281Rad54L, replacing the culture medium 16 h
later, harvesting conditioned medium after 16 h of exposure
to cells, and ﬁltering through a 0.45 mm pore-size syringe
ﬁlter. These preparations were then used to transduce
MO59KD32+Eco cells in the presence of 4 mg of Polybrene
(Sigma–Aldrich Corp., St. Louis, MO) per ml.
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Levels of the proteins of interest in cells relative to those in
control cells were measured by densitometry of standard
immunoblot analysis. Nuclear extracts were prepared from
minimum 10
5 cells as described previously (26) and protein
concentration determined using Bradford Reagent (Sigma–
Aldrich Corp.). Depending on the protein being analyzed
5o r1 0mg of total protein were loaded per lane for SDS–
PAGE. Rad54L, Rad54B and actin were detected with poly-
clonal goat antibodies D-18, N-16 and I-19, respectively
(Santa Cruz Biotechnology, CA). Anti-DNA-PKcs was a
rabbit polyclonal (Ab-1, Calbiochem, San Diego, CA)
and anti-RNA pol II was a mouse monoclonal (8WG16,
Covance Research Products, Denver, PA). Polyclonal rabbit
antibodies were used to detect SMC1a. Secondary detection
was done with horseradish peroxidase (HRP)–labeled porcine
anti-goat (Roche Biochemicals, Indianapolis, IN), goat anti-
rabbit or goat anti-mouse IgG2a antibodies (Jackson Immu-
noResearch Laboratories Inc., West Grove, PA). RNA pol
II and SMC1a which has previously been shown to be unaf-
fected by changes in DNA-PKcs (27) or b-actin, were used
for the loading controls for the shRNA knock-down experi-
ments. To accurately quantify the time-course of changes in
DNA-PKcs, Rad54L or Rad54B after shRNA knock-down,
enhanced chemiluminescence reagent was used for X-ray
ﬁlm detection and Enhanced Chemiluminescence Plus
reagent was used for densitometric image analysis (Storm
Scanner System, Amersham Biosciences). Quantiﬁcation
was performed by ImageQuant  software.
Isolation of rAAV DNA and preparation
of total cell lysates for slot-blot analysis
The isolation of low molecular weight plasmid DNA from
mammalian cells has been decscribed previously (28).
Brieﬂy, 3 · 10
5 transduced cells were lysed in the well
[0.6% SDS, 10 mM EDTA and 10 mM Tris–Cl (pH7.4)],
collected with a rubber policeman and digested with protei-
nase K (50 mg/ml) in the same buffer at 37 C overnight.
The high molecular weight DNA was precipitated with
NaCl (1 M ﬁnal) on ice overnight and removed by subsequent
centrifugation for 30 min at 4 C, 10 000g. The low molecular
weight DNA in the supernatant was extracted with phenol,
phenol–chloroform and chloroform. Viral DNA was then
ethanol precipitated in presence of glycogen as a carrier
(Roche Biochemicals, Indianapolis, IN) and dissolved in
distilled water (20 ml). Hirt extracted viral DNA was used
to transfect 293T cells by CaHPO4 precipitation. Total cell
lysates for slot-blot analysis were prepared from transduced
cells at different times after infection. Brieﬂy, cells were
trypsinized, counted, washed once with 1· PBS and re-
suspended in 400 ml lysis buffer (0.4 M NaOH and 10 mM
EDTA). The cell lysate was stored at  70 C for subsequent
analysis. For quantiﬁcation of rAAV DNA lysates were
thawn and 100 ml of each spotted onto a nylon membrane
using a slot-blot assembly (Bio-Rad, Hercules, CA). Serial
dilutions of appropriate plasmid DNA applied onto the
same membrane served as a reference for virus copy number.
Slots were washed twice with lysis buffer, the membrane
rinsed in 2· SSC and processed for hybridization with an
appropriate probe.
RESULTS
Generation of a gene targeting system for correction
of a mutant EGFP
To deﬁne the mechanism underlying rAAV-mediated gene
targeting we designed an appropriate model system for the
detection of targeting events. rAAV targeting has been repor-
ted in systems that require selection for the targeting events,
such as repair of the neomycin or HPRT gene (29). Others
evaluated frequencies of targeting AP (19), lacZ (16) and
GFP gene (30) under non-selective conditions. Antibiotic or
chemical selection may lead to inaccurate representation of
the number of targeting events. Therefore, we elected to
measure rAAV targeting frequency by direct detection of
EGFP ﬂuorescence in living cells and in the absence of selec-
tion. Since deletions are corrected by rAAV targeting much
more efﬁciently than insertions (19), we generated
EGFPD32 by deleting a 32 bp sequence including the chro-
mophore and simultaneously introduced an in-frame stop-
codon within a SpeI recognition site (Figure 1A). As
observed by microscopy (Supplementary Figure 1A) and
ﬂow cytometry (Supplementary Figure 1B) the MO59KD32
cells are GFP-negative, allowing the identiﬁcation of GFP
positive gene targeting products. Subsequently, polyclonal
population or clones containing the integrated EGFPD32
expression cassette were selected based on their resistance
to hygromycin. The presence of the targeting substrate was
conﬁrmed by Southern analysis of genomic DNA (data not
shown). Total RNA from both a polyclonal population and
individual clones, found to be positive for the insert, was sub-
jected to northern analysis in order to verify expression of the
mutant EGFPD32 mRNA. A signiﬁcant proportion of the
hygromycin resistant clones containing the construct lacked
the message (Supplementary Figure 1C), which can be attrib-
uted to previously reported strong and efﬁcient silencing of
the hCMV promoter in human cells (31) or to a disruption
of the EGFP gene following integration. Since gene repair
events would be undetectable in such non-expressing cells
in a polyclonal population, this could lead to a misrepresenta-
tion of the absolute targeting frequencies. Therefore, all of
the following experiments were carried out in both an
EGFPD32 polyclonal population and at least one clone with
conﬁrmed EGFPD32 mRNA expression. To exclude any pos-
sible locus-speciﬁc effects in the conﬁrmed clone, recombina-
tion frequencies were also estimated in EGFPD32 polyclonal
populations and their silenced derivatives.
Mutant EGFP is corrected by gene targeting with
homologous rAAV vectors
Gene targeting by rAAV vectors yielded variable success in
different systems [reviewed in (9)]. The system we gener-
ated had to exhibit robust frequencies of gene targeting to
enable identiﬁcation of changes upon modulation of DNA
repair pathways. Two rAAV vectors (rAAV-Neo, rAAV-
NeoX) (Figure 1B), were evaluated for their ability to med-
iate repair of the integrated target gene (EGFPD32) in
MO59KD32 cells. Prior to conducting targeting experiments
wild-type MO59K cells were transduced with 10 000 MOI
(as gcp/cell) of rAAV-Neo or rAAV-NeoX, and conﬁrmed
by ﬂow cytometry as GFP-negative (data not shown).
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of 30 homology as sufﬁcient for efﬁcient targeting (19).
Taking this into account the vectors were constructed with
174 bp of homology to the target upstream of the mutation,
and 568 to 1468 bp of downstream homology (Figure 1). It
has been suggested that the efﬁciency of gene targeting is
proportional to the virus load (29), and for most experi-
mental systems the optimal MOI was deﬁned empirically.
We determined the optimal experimental conditions for
gene targeting in the MO59KD32 cell line by transducing
the polyclonal population and two individual clones expres-
sing the EGFPD32 mRNA—MO59KD32 A and MO59KD32
B. The targeting rates were measured by counting the num-
ber of GFP positive cells 2 days after infection with either
rAAV-Neo or rAAV-NeoX at an increasing MOI
(Figure 2A). The infectivity of these two vectors was
found to be the same as judged indirectly by transduction
with rAAV-RFP or rAAV-RFPX (data not shown), which
have an RFP expression cassette replacing the Neo gene
expression (Figure 1C). In both polyclonal population and
clones the increase of homology between the viral vector
and the genomic target substantially enhanced the targeting
efﬁciency. The difference between the short 30-homology
vector (rAAV-Neo) and the long 30-homology vector
(rAAV-NeoX) at an MOI of 1000 was 50- to 70-fold. In
comparison, the increase in targeting rates was 46- to 100-
fold at an MOI of 10 000 and 10- to 24-fold at an MOI
of 50 000 when rAAV-NeoX was used instead of rAAV-
Neo. At the same time, increasing the vector dose from
10 000 to 50 000 MOI improved the targeting frequency
8 to 32 times for rAAV-Neo and up to four times for
rAAV-NeoX. This suggests that increased homology
improves targeting efﬁciencies and that this effect is
partially masked when higher virus load is applied to the
cells. The lower targeting frequency detected in the polyclo-
nal population compared to clone MO59KD32 B was
expected as suggested by the northern data (Supplementary
Figure 1C). The maximum EGFP repair frequency was
0.95% obtained with 50 000 MOI of rAAV-NeoX infection
of the MO59KD32 B clone, which made it a good candidate
for subsequent silencing experiments side by side with the
polyclonal MO59KD32 population.
Figure 2. Evidence of accurate gene correction. (A) Optimization of rAAV infection. A total of 3 · 10
5 cells of MO59KD32 polyclonal population
(diagonal stripes), clone MO59KD32 A (white columns) and clone MO59KD32 B (vertical stripes) were infected with rAAV-Neo (upper chart) or rAAV-NeoX
(lower chart) at the indicated MOI. The virus contaning medium was removed 24 h later. EGFP positive cells were counted by flow cytometry on day 2.
(B) Southern analysis of SpeI digested genomic DNA with a probe consisting of full-length EGFP. Wild-type MO59K cells (lane1) served as a negative control.
DNA from uninfected MO59KD32 B clone was loaded in lane 2. Lanes 3 to 10 contain genomic DNA from individual EGFP positive clones derived from
polyclonal rAAV-NeoX transduced population. DNA ladder sizes are shown to the right. A schematic bellow illustrates the variety of fragments that may arise
from head-to-tail (H-T *), head-to-head (H-H) or tail-to-tail (T-T) dimers of the targeting substrate integrated in the same genomic locus of MO59KD32 B.
The band arising from digestion of the EGFPD32 mutant with SpeI is marked by an arrowhead (‘+SpeI’). The fragment containing repaired EGFP that lacks SpeI
restriction site is marked with an arrow (‘ Spe I’). (C) PCR of genomic DNA amplifying 320 bp of corrected EGFP and 288 bp of mutant EGFPD32 fragment.
Lane 3 contains the products from rAAV-NeoX transduced polyclonal population. Lanes 4–6 represent product amplified from single clones derived from the
same polyclonal population. DNA from wild-type MO59K cells (lane 1) and EGFP expressing cell line (lane 7) were used as a negative and positive control,
respectively.
3350 Nucleic Acids Research, 2006, Vol. 34, No. 11Repair of the genomic EGFPD32 target occurs with
high fidelity
To analyze the outcome of the targeting events at a molecular
level, GFP positive cells were separated from the total trans-
duced MO59KD32 B population by single-cell sorting at day
5 post-infection. Genomic DNA from individual expanded
colonies was analysed by Southern blot comparing the foun-
der MO59KD32 B to targeted clones. SpeI-digested genomic
DNA identiﬁed MO59KD32 B (lane 2) as a multicopy clone
with respect to the targeting substrate (Figure 2B). Upon such
restriction digest a single copy of EGFPD32 should produce
two bands when hybridized to a full-length EGFP probe. In
MO59KD32 B the 4.3 kb band corresponds to a SpeI-digested
head-to-tail dimer integrated in the genome. The low intens-
ity of the 6.2 kb band suggests it represents the ‘head’ part of
the head-to-tail insert. This part shares only 190 bp of homol-
ogy with the probe and is unlikely to hybridize strongly to the
probe labeled by the random primer method. The more
intense 6.8 kb upper band is likely to represent the ‘tail’
part of the digested head-to-tail dimer, which contains the
remaining 500 bp of the EGFP gene thus producing much
stronger signal (Figure 2B schematic). This band could also
correspond in size with an additional copy of the target inte-
grated independently elsewhere in the genome thus increas-
ing the band intensity. However, multiple copies of the
target cannot reconstitute functional GFP unless an appropri-
ate rAAV vector introduces the correct sequence. This notion
is conﬁrmed by the SpeI digest of genomic DNA from EGFP
positive targeted clones, where all clones show a substantial
size-shift of a fragment resulting in a new band of  8.2 kb,
while some still retain the 6.8 kb band albeit with lower
intensity. This shift indicates loss of the SpeI restriction site
on a repaired EGFPD32 target. The appearance of an 8 kb
instead of 8.2 kb band-shift in lane 10 probably represents
a truncation that accompanied the repair event. The absence
of the 8.2 kb fragment in one of the analyzed clones indicates
lack of EGFPD32 repair (Figure 3B, lane 8). This clone was
selected as GFP positive at day 5 after infection, but the ﬂuor-
escence was lost after expansion. This suggests that a repair
of the mutant D14EGFP gene present on rAAV episomes may
occur instead of the genomic EGFPD32 target DNA. Sub-
sequently, the repaired episome could be degraded or
excluded during cell division. An additional band of about
5.3 kb in lane 5 represents an integration of virus DNA.
Aided by the multicopy nature of the targets in the analyzed
Figure 3. DNA-PKcs is not required for stable rAAV-mediated targeting. (A) Immunoblot analysis of specific RNAi-mediated silencing of DNA-PKcs in
MO59KD32 cells. Lane sh6684 and sh6684* depict the downregulation of DNA-PKcs expression pre- and post-infection, respectively. Sh11838 represents
inefficient downregulation of expression at the respective position of the mRNA. Nuclear extract from DNA-PKcs mutant MO59J cell line (derived from
MO59K) was used as a negative control. The relative level of residual protein expression with respect to MO59KD32 cells is shown at the bottom of each lane.
(B) Time-course analysis of rAAV infection. 3 · 10
5 cells were infected with rAAV-RFPX and the virus-containing medium removed 24 h later. Cells were
passaged and the percentage of RFP positive cells determined by FACS in fraction of the cells. (C and D) Time-course analysis of rAAV gene targeting. 3 · 10
5
cells were infected with 50 000 MOI of rAAV-NeoX. The virus was removed 24 h later and half of the cells assayed by FACS for GFP expression. The rest of the
cells were re-plated and subsequently used for analysis every other day.
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ing rAAV-mediated targeting. Notably, there was no change
in the size of the head-to-tail dimer band suggesting that it is
not a preferred target for the repair reaction and that most
probably single-strand annealing is an unlikely mechanism
of rAAV-mediated gene repair.
Next, the faithful repair of the EGFPD32 genomic target
was conﬁrmed by PCR analysis and sequencing of the
ampliﬁed products. The primer design allowed for the ampli-
ﬁcation of both wild-type EGFP (320 bp fragment) and the
mutant EGFPD32 (288 bp fragment) only from the integrated
substrate and not from the viral DNA. As evident from
agarose gel electrophoresis (Figure 2C) and sequencing
(Supplementary Figure 2) of the PCR products, individual
targeted EGFP positive clones contained the corrected frag-
ment of the EGFP gene, i.e. lacking the 32 bp deletion.
Together, these results demonstrate efﬁcient and accurate
repair of the EGFPD32 target with rAAV vectors.
DNA-PK is not required for rAAV-mediated
gene targeting
The unique hairpin-shaped ends of the AAV genome are
essential for rAAV gene targeting (19). A number of reports
show that DNA-dependent protein kinase (DNA-PKcs)
mediates the removal of the free DNA ends generated by
rAAV molecules by promoting their ligation into circular
intermediates in muscle and liver cells (17,32). In addition,
integration of AAV targeted to the AAVS1 site is increased
after antibody-depletion of DNA-PKcs (33). Other compo-
nents of the NHEJ pathway, such as KU86, have also been
found to assist in the processing of the rAAV genome in
cultured cells (18). Based on these observations we con-
sidered a role for DNA-PKcs in rAAV-mediated gene
targeting. Since NHEJ and HR may be competing (34), we
hypothesized that reduction of DNA-PKcs expression levels
could result in shift of the DSB repair pathways from
NHEJ to HR. In order to address any role of DNA-PKcs in
rAAV targeting, expression of DNA-PKcs in MO59KD32
cells was downregulated by RNAi. For short-term silencing
of gene expression both siRNA transfection and vector-
mediated expression of shRNA have proven effective. The
analysis of rAAV-mediated gene targeting was performed
over an extended period of time, which required stable tran-
scriptional knock-down of the gene. Therefore, populations
with reduced expression of DNA-PKcs of MO59KD32 poly-
clonal population and the MO59KD32 B clone were gener-
ated by transfection with linearized retrovirus vector
expressing shRNA from the RNA pol III promoter H1. Fol-
lowing selection on puromycin, nuclear extracts from these
cells were assayed by immunoblot for the presence of
DNA-PKcs, and for the constitutively expressed SMC1a
(27) used as a loading control (Figure 3A). There was a dra-
matic reduction in the protein level of DNA-PKcs reduced to
3.4% of the non-silenced MO59KD32 B cells, using the
shRNA starting at position 6684 of the mRNA. This silencing
effect was stable for more than one month as conﬁrmed in
nuclear extracts of cells infected with rAAV-NeoX
(Figure 3A). The shRNA at position 11 838 has been
shown previously to be efﬁcient in the form of transfected
siRNA (25). However, this sequence was not as efﬁcient in
our system and yielded only 40% reduction in protein levels
of DNA-PKcs.
The rates of gene targeting were compared in silenced
and normal MO59KD32 (Supplementary Figure 3A) and
MO59KD32 B cells (Figure 3). At day 0, 3 · 10
5 cells
were transduced with 50 000 MOI of rAAV-NeoX. Alternat-
ively, as a measure of infectivity, the same number of cells
were transduced with rAAV-RFPX. Following infection, the
number of GFP positive cells generated by gene targeting,
was measured by ﬂow cytometry in a fraction of the trans-
duced cells. Gene correction frequencies were represented
as the number of ﬂuorescent cells per 10
5 live cells counted.
The infectivity of silenced MO59KD32 B cells was margin-
ally higher, but not statistically signiﬁcant at a transduction
efﬁciency of  50% (Figure 3B). The highest number of
GFP positive cells was observed at day 3 after infection,
i.e. 5% in cells with silenced DNA-PKcs and 3% in normal
MO59KD32 B cells (Figure 3C). This number declined
rapidly over time stabilizing around two weeks after infec-
tion to about 0.02% for both cell populations (Figure 3D).
The large difference between the number of GFP positive
cells at day 3 and day 14 probably reﬂects gene targeting
that repairs the D14EGFP mutant present on the rAAV
episomes.
Preferential targeted repair of the GFP mutation
carried by the virus vector
Data in Figure 3C show that gene targeting frequencies
decline rapidly after infection. Theoretically, targeted repair
of a mutant may occur with the same probability either on
the genomic target or on the virus DNA. The kinetics of
these two events can be monitored separately in our system
(Figure 4A). Repair of the genomic target results in strong
ﬂuorescence from EGFP expression driven by the hCMV pro-
moter and early enhancer (Figure 4A; dashed GFP gate). In
contrast, weak EGFP expression of the repaired D14EGFP
mutant from the incomplete CBA promoter present in the
vector (see Materials and Methods) produced low ﬂuores-
cence intensity (undetectable by microscopy) (Figure 4A;
solid GFP gate). While up to day 7 the contribution of
rAAV episomes to the total number of ﬂuorescent cells was
signiﬁcant, targeting rates stabilized slowly thereafter and
the frequency of genomic target repair remained stable. To
evaluate the physical presence of EGFP expressing rAAV
episomes we isolated low molecular weight DNA from a
fraction of cells transduced with 10 000 MOI rAAV-NeoX
or rAAV-RFPX at day 5. This DNA, a mixture of single-
stranded and double-stranded rAAV genomes, was trans-
fected in 293T cells and GFP ﬂuorescence was assayed by
ﬂow cytometry 2 days later. Transfection with low molecular
weight DNA prepared from a cell line, which stably
expressed EGFP and was transduced with rAAV-SEAP
served as a negative control for potential contamination
with genomic DNA. Although  40% of the cells infected
with rAAV-RFPX expressed RFP, only 4.5 · 10
 3% of the
transfected cells were RFP positive (Figure 4B). Hence it
was not surprising that a gene targeting frequency of 0.93%
translated in 4.33 · 10
 4 % of 293T GFP positive cells
(Figure 4C). This assay only enabled visualization of episo-
mal EGFP expression, but not direct quantitation of rAAV
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cells transduced with 50 000 MOI of rAAV-NeoX were
prepared at one, two and three weeks post-infection. Ali-
quotes were spotted onto a membrane using a slot-blot adap-
tor and rAAV DNA was quantiﬁed by comparison with serial
dilutions of a plasmid control by hybridization with a vector
probe or a control probe (Figure 4D and E). The data from
this assay are summarized in Table 1. As evident from the
results, there were 215 viral DNA molecules per cell at day
7 and this number decreased drastically by day 15 to almost
undetectable at day 21. However, the gene targeting efﬁ-
ciency remained constant after two weeks of culture and
thus was sufﬁcient to observe differences after silencing of
recombination proteins.
Figure 4. Rapid removal of rAAV episomes results in reduced targeting rates. (A) FACS analysis of gene targeting in MO59KD32 cells at the indicated days
after transduction with rAAV-NeoX. GFP positive (%) gates define the number of cells with low and high fluorescence intensity of GFP. Targeted events
occurring on the virus DNA are represented by cells exhibiting low intensity of fluorescence (full line) and repair of the genomic target is measured by cells
exhibiting strong fluorescence (interrupted line). (B) FACS analysis of 293T cells transfected with low molecular weight DNA isolated from rAAV-RFPX
infected cells. (C) FACS analysis of 293T cells transfected with low molecular weight DNA isolated from rAAV-NeoX infected cells. (D) and (E) Slot-blot
analysis of of rAAV DNA isolated from total cell lysates at day 7, day 15 and day 21 post-infection. To quantify rAAV-NeoX DNA (D) a reference plasmid pTR-
NeoX was used for standard curve (STD) and the blot was hybridized with Neo probe. (E) Slot-blot membrane re-probed with a GAPDH probe to quantify
relative cell numbers.
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RAD54B levels
Based on the above data indicating no requirement for DNA-
PKcs in the targeting process, we elucidated possible factors
from the HR pathway that are important for rAAV targeting.
Most of the proteins in the RAD52 epistasis group were
recognized by their ability to aid homology-directed repair
of DNA DSBs induced by ionizing radiation [reviewed in
(35)]. There are no reports on the role of these proteins in
intracellular processing of the rAAV genome. Cell lines
where one of the members of this group, Rad54B, has been
eliminated, display greatly reduced frequency of gene target-
ing using linear plasmid DNA as compared to the wild-type
cells (36). Therefore, we examined the potential role of
RAD54B in the process of rAAV-mediated gene targeting.
RNAi-mediated silencing of RAD54B has no effect on cell
growth or cell survival. Four different shRNA sequences
were tested for their efﬁciency in silencing the expression
of RAD54B and the amount of remaining protein was
assessed in nuclear extracts by immunoblot (Figure 5A).
RNA pol II was used as a reference for protein loading.
The most potent oligonucleotide (starting position 1512 of
the RAD54B mRNA) reduced expression levels to 3.3% of
RAD54B expressed in the non-silenced MO59KD32 cells.
The infectivity of silenced and non-silenced cell populations
was assessed by transduction with rAAV-RFPX (Figure 5B).
We compared the gene targeting frequency in non-silenced
MO59KD32 B and derivatives of the same silenced with
sh1512 (Figure 5C and D and Supplemetary Figure 3C and
D). The targeting efﬁciency in cells with strongly silenced
RAD54B was more than 6-fold lower than the frequency in
non-silenced cells. To address whether the rate of gene target-
ing may depend on the level of protein expression we carried
Table 1. Stable gene targeting rates (starting at day 15) persist independently from the episomal rAAV-NeoX DNA




rAAV DNA/cell Targeting events
per 10
5 cells




MO59KD32 162.5 215.76 21.5 5.28 18 0.511
sh6684DNA-PK 210.0 238.90 23.5 8.48 16 4.016
Figure 5. Gene targeting frequency of rAAV corellates with RAD54B expression levels. (A) Immunoblot analysis of RAD54B-specific silencing. MO59KD32
designates the founder EGFPD32 expressing cell line. sh1409R54B, sh1512R54B, sh475R54B and sh1511R54B indicate the start position of the shRNA oligo on
the Rad54B mRNA. The relative level of residual protein expression with respect to the founder cells is shown at the bottom of each lane. (B) Monitoring of
infection efficiency. Cells were transduced with rAAV-RFPX and the number of RFP positive cells was counted by flow cytometry in aliquots from passaged
cells. (C and D) Time-course analysis of rAAV gene targeting. (D) shows a scaled-up version of the later time-points from (C).
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population with 71.9% residual RAD54B expression. Here,
the targeting frequency with respect to non-silenced cells
was reduced by 1.7- to 2-fold throughout the course of infec-
tion. The correlation between the protein levels of RAD54B
and the frequency of gene targeting suggests the importance
of HR for efﬁcient targeting.
RAD54L is necessary for efficient targeting
Disruption of Rad54 in mouse embryonic stem-cells and
chicken DT40 cells impairs HR and results in sensitivity to
ionizing radiation (37). Since our data show that RAD54B
is involved in the targeting process we hypothesized a role
for its homolog RAD54L, which is also a member of the
SWI2/SNF2 subfamily of DNA-dependent ATPases. To test
this hypothesis we used RNAi for silencing of RAD54L.
To further improve the generation of silenced polyclonal
populations we modiﬁed the MO59KD32 B clone by intro-
ducing an ecotropic receptor that enables retroviral entry.
The new cell line MO59KD32 B+Eco was infected with
retroviruses carrying shRNA designed to induce cleavage of
the RAD54L mRNA. Retrovirus MSCV-GFP was used to
monitor the efﬁciency of retrovirus infection that was for
the most part  50% (data not shown). RAD54L protein
levels were determined by immunoblot of nuclear extracts
from puromycin resistant polyclonal populations and com-
pared to that of non-silenced cells. Both actin and SMC1a
served as loading controls. Due to appearance of additional
bands in human cells a nuclear extract from Rad54 heterozy-
gous mouse ES cells was used to identify the RAD54L pro-
tein (83.4 kDa). Maximum reduction of RAD54L expression
was achieved by retrovirus infection with MSCV-sh1472
(Figure 7A), which reduced RAD54L levels to 7% of that
in non-silenced cells. As evident from data obtained after
transduction with rAAV-RFPX, untreated and RAD54L
silenced cells have the same infectivity (Figure 6B). We
measured the frequency of gene targeting in MO59KD32
B+Eco and silenced population after transduction with
50000 MOI of rAAV-NeoX (Figure 6C). Similar to
RAD54B, strong silencing of RAD54L lead to impaired
rAAV-mediated targeting, which translated to 3.5-fold reduc-
tion of targeting rates at the beginning of infection and stabi-
lized at 2-fold by day 9 after infection. Weak silencing with
sh2281 (70.2% of residual RAD54L expression) yielded no
difference between the targeting rates in the founder cell
line and its silenced counterpart. However, the lack of
RAD54L had a pronounced effect on the ﬁdelity of gene
Figure 6. Strong inhibition of RAD54L expression leads to reduced rAAV targeting frequency. (A) Immunoblot analysis of Rad54L-specific silencing.
MO59KD32 B+Eco designates the founder MO59KD32 B clone expressing Ecotropic receptor. sh1472R54L, sh2281R54L and sh1396R54L indicate the start
position of the retrovirally expressed shRNA oligo on the RAD54L mRNA. SMC1a and b-actin were used as loading controls and nuclear extract from mouse
ES Rad54± cells was used as a RAD54 size-reference. (B) Time-course analysis of rAAV infection. MO59KD32 B+Eco cells and RAD54L silenced polyclonal
populations were transduced with rAAV-RFPX to test infectivity. The fraction of cells expressing RFP was determined every other day in an aliquot of passaged
cells. (C) Gene targeting of MO59KD32 B+Eco and RAD54L silenced cells. 5 · 10
5 cells were transduced with 50 000 MOI of rAAV-NeoX and GFP positive
cells detected by flow cytometry on alternate days starting 24 h after infection.
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genomic DNA of sorted cells positive by FACS revealed
high rate of base substitutions—three in the stretch of
36 bp (Supplementary Figure 2B). This observation indicates
that in the absence of RAD54L and probably other HR pro-
teins rAAV utilizes other DNA mechanisms of interaction
with the cellular genome.
XRCC3 deficiency blocks stable gene correction
by rAAV
The above results indicate the dependence of rAAV-mediated
targeting on components of the HR pathway of DNA DSB
repair. For a factor further upstream in the Rad52 pathway,
we silenced expression of the Rad51 paralog XRCC3, the
absence of which did not affect the growth rate of irs1SF
cells, a CHO-derived line (38).
MO59KD32 cells were transfected with shRNA
expressing vectors targeting the XRCC3 mRNA at positions
362, 367, 914 and 2059. Since no reliable antibodies for
XRCC3 detection by immunoblot were available to us, the
level of downregulation of XRCC3 expression was deter-
mined by northern analysis of total RNA from puromycin
resistant polyclonal populations (Figure 7A). The house-
keeping gene GAPDH was used as an internal loading
control. The most efﬁcient silencing was achieved with
the shRNA starting at position 367, which reduced
XRCC3 mRNA level to 23.2% from that of untreated cells,
and this silenced population was chosen for subsequent
gene targeting experiments. Transduction of silenced and
non-silenced cells with rAAV-RFPX showed they possess
the same rate of infectivity (Figure 7B). Silencing of
XRCC3 also did not affect the cell growth. A gene targeting
experiment was carried out in parallel by transduction of
silenced and non-silenced cells with 50000 MOI of
rAAV-NeoX (Figure 7C and D). Decrease of XRCC3
mRNA had a negative effect on both short- and long-term
gene targeting, which was much more pronounced at later
time-points. While the decrease in targeting efﬁciency was
about 3-fold at days 3 and 5 after the infection (Figure 7C),
it amounted to 10-fold at day 11 and there were no GFP
positive cells after day 13 post-infection (Figure 7D).
This rather dramatic effect of XRCC3 deﬁciency on rAAV
targeting is consistent with the above results suggesting
that the RAD51/RAD54 HR pathway controls this
process.
Figure 7. Suppression of XRCC3 abolishes long-term gene correction. (A) Northern analysis of XRCC3 silencing. MO59KD32 designates the founder cell line
and sh914, sh2059, sh362 and sh367 indicate the type of shRNA used to downregulate XRCC3 expression in the respective puromycin resistant population the
total RNA was isolated from. GAPDH was used as an internal control to normalize for loading. (B) Comparison of infectivity of silenced and non-silenced cells.
MO59KD32 B and their sh367XRCC3 derivative were transduced with rAAV-RFPX. As a measure of infection efficiency the level of RFP expression in the total
cell population was monitored on alternate days. (C) Gene targeting in non-silenced and XRCC3 silenced cells. MO59KD32 B and sh367XRCC3 cells were
transduced with 50 000 MOI of rAAV-NeoX. The GFP positive cells were detected by flow cytometry every other day for 15 days after infection. (D) Enlarged
version of (C) spanning day 7 to day 15 after infection, which enables viewing the number of stable targeting events in detail.
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Understanding the mechanisms underlying the process of
rAAV-mediated gene targeting shown previously to reach
unusually high frequencies (29,39) will likely be beneﬁcial
for gene therapy applications and will contribute to our
knowledge of virus-host interactions and DNA dynamics.
We utilized RNA interference to examine the role of cellular
proteins involved in DNA repair and recombination pathways
for rAAV-mediated gene targeting. Compared with the non-
silenced parent populations, all polyclonal silenced popula-
tions proliferated with the same rate and contained similar
numbers of RFP positive cells indicative of infection. There-
fore, the silencing procedure does not seem to affect paramet-
ers critical for a valid comparison of targeting rates, such as
the kinetics of rAAV transduction, surface receptor expres-
sion, or growth properties of the cells.
Several types of mutations have been efﬁciently corrected
using rAAV vectors [reviewed in (9)]. In our system, rAAV
targeting vectors achieve high ﬁdelity correction of a 32 bp
deletion at a stable, long-term targeting frequency of 0.02%
consistent with previous observations made under non-
selective conditions. Also consistent with earlier reports, we
observed signiﬁcant improvement in the frequency of repair
with the increase of the vector load. Besides efﬁcient delivery
of vector DNA, the length of homology between vector and
target proved important. A 2-fold extension of the 30 homol-
ogy between the chromosomal substrate and the recombinant
viral vector resulted in an increase in the repair frequency of
up to 73-fold at low, 101-fold at intermediate and 23-fold at
high vector dose. The length of homology that can be
included in the rAAV system is limited by the packaging
capacity of the virus, which is about 4.7 kb, and for maximal
targeting efﬁciency at low MOI the longest possible homol-
ogy should be used. Still, the rAAV system requires less
extended homology than conventional targeting systems at
mostly higher targeting frequencies.
We have tested the effect of silencing several genes that
are key to NHEJ and HR, including DNA-PK, RAD54L,
RAD54B or XRCC3. Cell lines deﬁcient in either Rad54L
Figure 8. Possible mechanism of gene targeting by rAAV. After the viral capsid has been removed RPA may bind to the single-stranded AAV genome and
support initiation of HR. The BRCA2-RAD51 complex, assisted by RAD51 paralogs, such as XRCC3, replaces RPA with RAD51. The nucleoprotein filament
finds and pairs with the homologous chromosomal sequence via unwinding/supercoiling facilitated by RAD54. Non-crossover gene conversion by repair DNA
synthesis can occur either on the virus DNA (as shown here) or on the chromosomal target. Alternatively, resolution of vector-chromosomal DNA intermediates
(arrows mark the two possible options) results in introduction of targeted modification in the homologous chromosome by crossing over and exchange of
sequences. Only two of four possible outcomes are shown. The images may not represent the actual sequence of events.
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and XRCC3 are viable (24,36,38,40), rendering RNA inter-
ference feasible.
Absence of DNA-PK reduces circularization of linear
dsrAAV genomes by about 50% (17) and one member of
the DNA–PK complex, KU86, apparently binds to rAAV
DNA, and acts as an inhibitor of rAAV transduction (18).
In this report, we demonstrate that rAAV gene targeting
does not depend on NHEJ since transcriptional silencing of
DNA-PKcs does not affect targeting frequencies. It is likely
that the higher number of GFP positive cells in the DNA-
PKcs silenced population observed at day 3 (Figure 3C) is
due to reduced circularization and abundance of linear
rAAV monomer genomes, which have been shown to be
effective in targeting (19).
However, we identiﬁed components of the RAD51/RAD54
pathway of HR as central to rAAV-mediated gene targeting.
We found that reduced protein levels of the two Rad54-
homologous genes in human cells, RAD54L and RAD54B
result in decreased stable rAAV-mediated targeting rates by
2- and 6-fold, respectively. RAD54L and RAD54B are mem-
bers of the RAD52 epistasis group and belong to the SNF2/
SWI2 family of proteins that dissociate and remodel protein
complexes on DNA (40,41). Our data are consistent with
up to 10-fold reduced targeting frequencies in colon cancer
cell lines with inactivated RAD54B (36). RAD54L facilitates
strand-exchange by RAD51, which binds to RAD54L and sti-
mulates its ATPase activity (42). Since the yeast homologue
of RAD54B, TID1/RDH54 acts in the same recombinational
repair pathway as RAD54L via roles partially overlapping
with those of RAD54 the residual levels of targeting we
observed in the absence of either protein were to be expected.
Lack of reports on the viability and proliferative capacity of
cells deﬁcient in both RAD54L and RAD54B, renders the
outcome of a potential double silencing experiment to test
this functional redundancy in HR very uncertain.
RAD51 plays a central role in HR by replacing RPA from
single-stranded DNA and forming a nucleoprotein ﬁlament
that participates in homologous pairing (35). Disruption of
the RAD51 gene leads to cell death (43), whereas RAD51
paralogs including XRCC3 are not essential for cell viability.
The XRCC3-deﬁcient X-ray sensitive hamster cell line,
irs1SF shows increased chromosome mis-segregation (44)
and has a 25-fold decrease in the frequency of error-free
homology-directed repair of DNA DSBs (38). Both can be
restored to wild-type levels through XRCC3 expression
(44). However, in contrast to RAD51, XRCC3 is known to
act in the early as well as late stages of HR (45,46). Follow-
ing reduction of XRCC3 mRNA levels we observed nearly
complete elimination of rAAV-mediated gene targeting,
which may reﬂect the multiple roles XRCC3 plays in HR.
Although the reduction in XRCC3 mRNA was about 80%
compared to mRNA levels in non-silenced cells, the remain-
ing XRCC3 protein may be below a critical concentration. A
complex between XRCC3 and another RAD51 paralog,
RAD51C associates speciﬁcally with single-stranded DNA
(47) and modulates replication fork progression by slowing
it down after DNA damage (48). The complex also plays a
role probably downstream of RAD54 in the HR pathway,
i.e. as a resolvase of Holliday junctions (49). Thus, resolution
of recombination intermediates and/or triggering of DNA
damage-related signaling present two of the possible roles
for the XRCC3/RAD51C complex in rAAV targeting. A
recent report reveals that XRCC3 forms nuclear foci indepen-
dently of RAD51 very early during homology-directed DSB
repair, associates directly with DNA, and promotes formation
of the RAD51 nucleoprotein ﬁlament (45). One may hypothe-
size, that the absence of XRCC3 affects potential binding of
RAD51 to the single-stranded AAV vector genome and sub-
sequently its homologous pairing with the chromosomal locus
during the targeting reaction. Based on this hypothesis we
propose a molecular model for the mechanism of rAAV-
mediated targeting in human cells (Figure 8). Removal of
capsid proteins exposes the single-stranded AAV genome,
allowing its degradation by nucleases. There are several pro-
cesses that could prevent this degradation: annealing of pos-
itive and negative viral genomes, second-strand synthesis, or
coating of the single-stranded region by high-afﬁnity single-
stranded DNA-binding proteins, such as RPA. RPA, a hetero-
trimer with multiple roles in DNA replication and repair, may
ensure proper initiation of HR by preventing secondary struc-
ture formation from single-stranded DNA, thus supporting
even coating by RAD51. It is unknown, however, whether
RPA affects the structure of the rAAV ITRs. The RAD51C/
XRCC3 heterodimer binds single-stranded AAV DNA at a
terminal repeat site that resembles a DNA break (50), and
through direct interactions between XRCC3 and RAD51
mediates the formation of the RAD51 nucleoprotein ﬁlament.
RAD51 is likely derived from a mobile pool or from a
BRCA2 complex, which also has a high binding afﬁnity for
ds- to single-stranded DNA transitions (51,52). Following
ATP binding and hydrolysis by XRCC3 the RAD51C/
XRCC3 dimer may be destabilized (53). RAD54L and prob-
ably RAD54B interact with the RAD51 ﬁlament, unwind the
ds genomic target DNA, and may remove nucleosomes from
the homologous locus in order to prepare for pairing with the
rAAV DNA. After pairing with the homologous target the
resulting intermediate can be resolved either by crossing
over and Holliday junction resolution or by the predominant
pathway for DSB repair in mammalian cells—non-crossover
gene conversion (54,55). The rAAV DNA serves as a tem-
plate for repair of the chromosomal target, however, gene
conversion can occur on the virus with the genomic sequence
as a template.
Our system shares signiﬁcant similarity with a yeast model
for gene targeting where donation of information to an unbro-
ken chromosome is facilitated by a linearized plasmid (56).
The authors suggest this process occurs via the formation
of a heteroduplex intermediate and the efﬁciency of donation
depends on the spatial distribution of heteroduplex DNA. The
frequency of donation was proportional to the increased dis-
tance from the break to the mutation and always resulted
from a single gene conversion event, which is very likely
to be the case with rAAV targeting.
The conclusion that rAAV targeting depends on HR is in
concert with recent evidence that targeting occurs with higher
frequency in actively replicating cells, presumably the S
phase of the cell cycle (30,57). NHEJ and HR function in a
complementary, overlapping manner (58) and the cell cycle
phase determines the prevalence of one or the other repair
process. A predominant role for NHEJ early in the cell
cycle in mammalian cells is supported for example by the
3358 Nucleic Acids Research, 2006, Vol. 34, No. 11high IR sensitivity of NHEJ-defective cells in the G1 phase
(59), while HR seems to occur mostly during S and G2/M
phases (58).
A notable ﬁnding in our study is the signiﬁcant decrease of
GFP positive cells within 5 days after infection. This
phenomenon has not yet been reported. Some of the rAAV
targeting systems measured the number of events after an
extended period of antibiotic selection (29). Other systems
are based on staining of the cells at a particular time point
after infection (16,19). In yet another system, which uses
GFP as a readout in living cells, the results were given for
only one time point, i.e. as positive foci at day 7 (30). The
higher number of GFP positive cells at early time-points
could also imply asymmetric recognition of the rAAV ITRs
by a component of the cellular recombination machinery.
That is, gene conversion on the viral vector instead of on
the genomic target may have occurred. This may happen,
for example, if a nick occurs at a hot-spot on the viral
DNA within the double-stranded (60,61) or single-stranded
region with subsequent invasion and copying of the chromo-
somal DNA sequence to repair the vector mutation. The
unusual structure of the ITRs and the ss–ds transitional
regions may be likely targets for nucleases.
Our results together with previous data provide the
groundwork for improvement of the rAAV targeting fre-
quency by shifting the balance from the NHEJ to the HR
pathway. Since DNA-PK does not affect gene targeting,
speciﬁc inhibition of DNA-PK with chemically synthesized
small molecules (62), which has been shown to enhance
gene conversion (63), combined with overexpression of
proteins promoting HR (64) or synchronization of cells in
S phase (for targeting of stem-cells) would enhance further
targeting efﬁciencies increasing the potential for therapeutic
applications.
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